Showing 1 - 6 results of 6 for search 'Lintong Yao', query time: 0.03s Refine Results
  1. 1
    Identification of Prognostic Model Based on Immune-Related LncRNAs in Stage I-III Non-Small Cell Lung Cancer

    Identification of Prognostic Model Based on Immune-Related LncRNAs in Stage I-III Non-Small Cell Lung Cancer by Qiaxuan Li, Qiaxuan Li, Lintong Yao, Lintong Yao, Zenan Lin, Fasheng Li, Fasheng Li, Daipeng Xie, Congsen Li, Congsen Li, Weijie Zhan, Weijie Zhan, Weihuan Lin, Luyu Huang, Luyu Huang, Shaowei Wu, Shaowei Wu, Haiyu Zhou, Haiyu Zhou, Haiyu Zhou, Haiyu Zhou

    Published 2021-10-01
    Get full text
    Article
  2. 2
    Homologous recombination repair rathway and RAD54L in early-stage lung adenocarcinoma

    Homologous recombination repair rathway and RAD54L in early-stage lung adenocarcinoma by Shaopeng Zheng, Lintong Yao, Fasheng Li, Luyu Huang, Yunfang Yu, Zenan Lin, Hao Li, Jin Xia, Michael Lanuti, Haiyu Zhou

    Published 2021-02-01
    Get full text
    Article
  3. 3
    Combining autophagy and immune characterizations to predict prognosis and therapeutic response in lung adenocarcinoma

    Combining autophagy and immune characterizations to predict prognosis and therapeutic response in lung adenocarcinoma by Qiaxuan Li, Qiaxuan Li, Daipeng Xie, Daipeng Xie, Lintong Yao, Lintong Yao, Hongrui Qiu, Hongrui Qiu, Peimeng You, Jialong Deng, Congsen Li, Congsen Li, Weijie Zhan, Weijie Zhan, Maotao Weng, Maotao Weng, Shaowei Wu, Shaowei Wu, Fasheng Li, Yubo Zhou, Fanjun Zeng, Yong Zheng, Haiyu Zhou, Haiyu Zhou, Haiyu Zhou

    Published 2022-09-01
    Get full text
    Article
  4. 4
    A homologous and molecular dual-targeted biomimetic nanocarrier for EGFR-related non-small cell lung cancer therapy

    A homologous and molecular dual-targeted biomimetic nanocarrier for EGFR-related non-small cell lung cancer therapy by Bin Xu, Fanjun Zeng, Jialong Deng, Lintong Yao, Shengbo Liu, Hengliang Hou, Yucheng Huang, Hongyuan Zhu, Shaowei Wu, Qiaxuan Li, Weijie Zhan, Hongrui Qiu, Huili Wang, Yundong Li, Xianzhu Yang, Ziyang Cao, Yu Zhang, Haiyu Zhou

    Published 2023-09-01
    Get full text
    Article
  5. 5
    KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials

    KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials by Hongyuan Zhu, Hongyuan Zhu, Daipeng Xie, Yunfang Yu, Lintong Yao, Bin Xu, Luyu Huang, Shaowei Wu, Fasheng Li, Yating Zheng, Xinyi Liu, Wenzhuan Xie, Mengli Huang, Hao Li, Shaopeng Zheng, Dongkun Zhang, Guibin Qiao, Lawrence W. C. Chan, Haiyu Zhou

    Published 2021-07-01
    Get full text
    Article
  6. 6
    Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB–IV NSCLC (LCDigital-IO Study): a multicenter retrospective study

    Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB–IV NSCLC (LCDigital-IO Study): a multicenter retrospective study by Bin Xu, Lan Liu, Shaowei Wu, Guangyi Wang, Guibin Qiao, Weijie Zhan, Daipeng Xie, Lintong Yao, Henian Yao, Guoqing Liao, Luyu Huang, Yubo Zhou, Peimeng You, Zekai Huang, Qiaxuan Li, Siyun Wang, Dong-Kun Zhang, Lawrence Wing-Chi Chan, Michael Lanuti, Haiyu Zhou

    Published 2023-10-01
    Get full text
    Article

Search Tools: